• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Varicose veins: next turf war?

Article

It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to Cornell University researchers. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.

It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to Cornell University researchers. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.

The study was presented in January at the 15th Annual International Symposium on Endovascular Therapy.

Approved by the FDA in January 2002, laser treatment can be performed in an outpatient setting and is less expensive than surgery, with little reported patient discomfort.

"Most of the people qualified to perform this procedure should be interventional radiologists, but over the next couple of years there'll be thousands of physicians doing it, including vascular and general surgeons and even dermatologists," said Dr. Robert Min, coauthor and director of Cornell's new vascular center.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.